These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 1392660

  • 21. [Present aspects and problems regarding occupational bladder cancer due to exposure to aromatic amines].
    Yamamura J.
    J UOEH; 1989 Dec 01; 11(4):495-504. PubMed ID: 2692109
    [Abstract] [Full Text] [Related]

  • 22. [Bladder cancer and occupational activity].
    Porru S, Scotto di Carlo A, Carta A, Placidi D.
    G Ital Med Lav Ergon; 2003 Dec 01; 25(3):298-300. PubMed ID: 14582243
    [Abstract] [Full Text] [Related]

  • 23. Etiology of bladder cancer.
    Shirai T.
    Semin Urol; 1993 Aug 01; 11(3):113-26. PubMed ID: 8210833
    [Abstract] [Full Text] [Related]

  • 24. Occupational exposure to aromatic amines: benzidine and benzidine-based dyes.
    Walker B, Gerber A.
    Natl Cancer Inst Monogr; 1981 Dec 01; (58):11-3. PubMed ID: 7341968
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Nonsmoking-related arylamine exposure and bladder cancer risk.
    Skipper PL, Tannenbaum SR, Ross RK, Yu MC.
    Cancer Epidemiol Biomarkers Prev; 2003 Jun 01; 12(6):503-7. PubMed ID: 12814994
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Biomarkers of exposure, effect, and susceptibility in workers exposed to nitrotoluenes.
    Sabbioni G, Jones CR, Sepai O, Hirvonen A, Norppa H, Järventaus H, Glatt H, Pomplun D, Yan H, Brooks LR, Warren SH, Demarini DM, Liu YY.
    Cancer Epidemiol Biomarkers Prev; 2006 Mar 01; 15(3):559-66. PubMed ID: 16537716
    [Abstract] [Full Text] [Related]

  • 32. Genetic susceptibility and occupational cancer.
    Hayes RB.
    Med Lav; 1995 Mar 01; 86(3):206-13. PubMed ID: 7565279
    [Abstract] [Full Text] [Related]

  • 33. [Biomarkers of gentotoxic risk and metabolic polymorphism].
    Pavanello S, Clonfero E.
    Med Lav; 2000 Mar 01; 91(5):431-69. PubMed ID: 11189784
    [Abstract] [Full Text] [Related]

  • 34. [Urothelial carcinoma related to exposure to aromatic amines].
    Naito S, Kumazawa J.
    Hinyokika Kiyo; 1989 Dec 01; 35(12):2023-31. PubMed ID: 2618901
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Environmental and chemical carcinogenesis.
    Wogan GN, Hecht SS, Felton JS, Conney AH, Loeb LA.
    Semin Cancer Biol; 2004 Dec 01; 14(6):473-86. PubMed ID: 15489140
    [Abstract] [Full Text] [Related]

  • 37. Cytologic detection of urothelial cancer and other abnormalities in a cohort of workers exposed to aromatic amines.
    Crosby JH, Allsbrook WC, Koss LG, Bales CE, Witherington R, Schulte PA, Hemstreet G, Ringer K.
    Acta Cytol; 1991 Dec 01; 35(3):263-8. PubMed ID: 2042428
    [Abstract] [Full Text] [Related]

  • 38. The genetic and environmental factors involved in benzidine metabolism and bladder carcinogenesis in exposed workers.
    Carreón T, LeMasters GK, Ruder AM, Schulte PA.
    Front Biosci; 2006 Sep 01; 11():2889-902. PubMed ID: 16720360
    [Abstract] [Full Text] [Related]

  • 39. Optimal management of asymptomatic workers at high risk of bladder cancer.
    Schulte PA, Ringen K, Hemstreet GP.
    J Occup Med; 1986 Jan 01; 28(1):13-7. PubMed ID: 3950777
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.